Abstract
The Lipoprotein-apheresis (LA) devices used in North America for Familial Hypercholesterolemia (FH) reduce LDL-C (− 80%) by binding positive charged apolipoprotein B (apoB) to a negative charged environment. FH patients also have low HDL-C levels, and despite their negative charge, HDL-C is
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
